Skip to main content
SpringerLink
Log in

Drug-Induced Injuries of the Liver and Biliary Tract

  • Conference paper
Drug-Induced Injury to the Digestive System

  • 76 Accesses

Abstract

Hepatic and biliary drug reactions have been increasingly recognized as major causes of liver and biliary tract diseases over the last 20 years [37, 66, 85, 90]. This may be explained by several factors. First, marked improvements have been made in diagnostic methods (viral serologic tests, ultrasonography, tomodensitometry, magnetic resonance imaging), allowing elimination of other causes of disease and ascertainment of potential involvement of drug reactions more accurately. Thus, the hepatotoxicity of some drugs, such as amiodarone or amodiaquin used for more than 25 years, was only recognized a few years ago [36, 70].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson SD, Nolley HC, Berland LL, Van Dyke JA, Stanley R (1986) Causes of jaundice during hepatic artery infusion chemotherapy. Radiology 161: 439–442

    PubMed  CAS  Google Scholar 

  2. Anthony PP (1988) Liver tumours. Bailliere’s Clin Gastroenterol 2: 501–522

    Article  CAS  Google Scholar 

  3. Babany G, Uzzan F, Larrey D, Degott C, Bourgeois C, René E, Vissuzaine C, Erlinger S, Benhamou JP (1989) Alcoholic-like liver lesions induced by nifedipine. J Hepatol 9: 252–255

    Article  PubMed  CAS  Google Scholar 

  4. Beaugrand M, Denis J, Callard P (1987) Tous les inhibiteurs calciques peuvent-ils entraîner des lésions d’hépatite alcoolique? Gastroenterol Clin Biol 10: 76

    Google Scholar 

  5. Beaune PH, Dansette PM, Mansuy D et al. (1987) Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Nat Acad Sci USA 84: 551–555

    Article  PubMed  CAS  Google Scholar 

  6. Belghiti J, Benhamou JP, Houry S, Grenier P, Huguier M, Fekete F (1986) Caustic sclerosing cholangitis. A complication of the surgical treatment of hydatid disease of the liver. Arch Surg 121: 1162–1165

    Article  PubMed  CAS  Google Scholar 

  7. Benichou C and an international group of experts (1990) Criteria of drug-induced liver disorders. J Hepatol 11: 272–276

    Article  PubMed  CAS  Google Scholar 

  8. Biour M, Poupon R, Grange JD, Chazouilleres O, Levy VG, Bodin F, Cheymol G (1991) Hépatotoxicité des médicaments. Mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables. Gastroenterol Clin Biol 15: 64–78

    PubMed  CAS  Google Scholar 

  9. Bjorge SM, Baillie TA (1985) Inhibition of medium-chain fatty acid ß-oxidation in vitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid. Biochem Biophys Res Com 132: 245–252

    Article  PubMed  CAS  Google Scholar 

  10. Bourdi M, Larrey D, Nataf J, Bernuau J, Pessayre D, Iwasaki M, Guengerich FP, Beaune PH (1990) Anti-liver endoplasmic reticulum auto-antibodies are directed against human cytochrome P-450 IA2. A specific marker of dihydralazine-induced hepatitis. J Clin Invest 85: 1967–1973

    Article  PubMed  CAS  Google Scholar 

  11. Daudon M, Reveillaud RJ, Bigorie B (1988) Lithiase médicamenteuse du cholédoque. Presse Med 17: 869

    PubMed  CAS  Google Scholar 

  12. Davion T, Capron JP (1991) Epidémiologie et facteurs de risque de la lithiase biliaire. In: Erlinger S, éd. La lithiase biliaire. Paris: Doin: 1–15

    Google Scholar 

  13. Degott C, Feldmann G, Larrey D, Durand-Schneider AM, Grange D, Machayekhi JP, Moreau A, Potet F, Benhamou JP (1992 Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia. Hepatology 15: 244–251

    Article  PubMed  CAS  Google Scholar 

  14. Degott C, Rueff B, Kreis H, Duboust A, Potet F, Benhamou JP (1978) Peliosis hepatis in recipients of renal transplants. Gut 19: 748–753

    Article  PubMed  CAS  Google Scholar 

  15. De La Inglesia FA, Feuer G, Takada A, Matsuda Y (1974) Morphologic studies on secondary phospholipidosis in humans. Lab Invest 4: 539–549

    Google Scholar 

  16. Dikengil A, Siskind BN, Morse SS, Swedlund A, Bober-Sorcinelli KE, Burrel MI (1986) Sclerosing cholangitis from intra-arterial floxuridine. J Clin Gastroenterol 8: 690–693

    Article  PubMed  CAS  Google Scholar 

  17. Dowling RH, Hussaini SH, Murphy GM, Besser GM, Wass JAH (1992) Gallstones during octreotide therapy. Metabolism 41: 22–33

    Article  PubMed  CAS  Google Scholar 

  18. Dutertre JP, Bastides F, Jonville AP, De Muret A, Sonneville A, Larrey D, Autret E (1991) Microvesicular steatosis after ketoprofen administration. Eur J Gastroenterol Hepatol 3: 953–954

    Google Scholar 

  19. Eade OE, Grice D, Krawitt EL et al. (1981) HLA A and B locus antigens in patients with unexplained hepatitis following halothane anaesthesia. Tissue Antigens 17: 428–432

    Article  PubMed  CAS  Google Scholar 

  20. Farrell G, Prendergast D, Murray M (1985) Halothane hepatitis. Detection of a constitutional susceptibility factor. N Engl J Med 313: 1310–1314

    Article  PubMed  CAS  Google Scholar 

  21. Forbes GM, Jeffrey GP, Shilkin KB, Reed WD (1992) Carbamazepine hepato-toxicity: another cause of the vanishing bile duct syndrome. Gastroenterology 102: 1385–1388

    PubMed  CAS  Google Scholar 

  22. Freneaux E, Larrey D, Pessayre D (1988) Stéatoses hépatiques médicamenteuses à triglycérides. Rev Fr Gastroenterol 240: 873–884

    Google Scholar 

  23. Geneve J, Hayat-Bonan B, Degott C, Letteron P, Freneaux E, Le Dinh T, Larrey D, Pessayre D (1987) Inhibition of mitochondrial β-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal antiinflammatory drug. J Pharmacol Exp Ther 242: 1133–1137

    PubMed  CAS  Google Scholar 

  24. Heim-Duthoy KL, Caperton EM, Pollock R, Matzke GR, Enthoven D, Peterson PK (1990) Apparent biliary pseudolithiasis during ceftriaxone therapy. Anti-microb Agents Chemother 34: 1146–1149

    CAS  Google Scholar 

  25. Homberg JC, Abuaf N, Helmy-Khalil S, Biour M, Poupon R, Islam S, Darnis F, Levy VG, Opolon P, Beaugrand M, Toulet J, Danan G, Benhamou JP (1985) Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology 5: 722–727

    Article  PubMed  CAS  Google Scholar 

  26. Horsmans Y, Lannes D, Pessayre D, Larrey D. (1991) Possible relationship between Atrium-induced hepatotoxicity and the genetic polymorphism in mephenytoin oxidation. Gastroenterology 100: A 828

    Google Scholar 

  27. Horsmans Y, Larrey D, Pessayre D, Benhamou JP (1990) Hépatotoxité des médicaments anti-infectieux. Première partie: Les antibiotiques antibactériens. Gastroenterol Clin Biol 14: 911–918

    PubMed  CAS  Google Scholar 

  28. Ishak KG, Irey NS (1972) Hepatic injury associated with the phenothiazines. Clinico-pathologic and follow-up study of 36 patients. Arch Pathol 93: 283–304

    PubMed  CAS  Google Scholar 

  29. Ishak KG, Zimmermann HJ (1987) Hepatotoxic effects of the anabolic-androgenic steroids. Semin Liver Dis 7: 230–236

    Article  PubMed  CAS  Google Scholar 

  30. Ishak KG, Zimmermann HJ (1988) Drug-induced and toxic granulomatous hepatitis. Baillere’s clin gastroenterol 2: 463–480

    Article  CAS  Google Scholar 

  31. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 107: 459–465

    PubMed  CAS  Google Scholar 

  32. Larrey D, Amouyal G, Danan G, Degott C, Pessayre D, Benhamou JP (1987) Prolonged cholestasis after troleandomycin-induced acute hepatitis. J Hepatol 4: 327–329

    Article  PubMed  CAS  Google Scholar 

  33. Larrey D, Amouyal G, Pessayre D, Degott C, Danne O, Machayekhi JP, Feldmann G, Benhamou JP (1988) Amitriptyline-induced prolonged cholestasis. Gastroenterology 94: 200–203

    PubMed  CAS  Google Scholar 

  34. Larrey D, Babany G, Bernuau J, Andrieux J, Degott C, Pessayre D, Benhamou JP. (1990) Fulminant hepatitis after lisinopril administration. Gastroenterology 99: 1832–1833

    PubMed  CAS  Google Scholar 

  35. Larrey D, Berson A, Habersetzer F, Tinel M, Castot A, Babany G, Lettéron P, Freneaux E, Loeper J, Dansette P, Pessayre D (1989) Genetic predisposition to drug hepatotoxicity. Role in hepatitis caused by amineptine, a tricyclic antidepressant. Hepatology 10: 168–173

    Article  PubMed  CAS  Google Scholar 

  36. Larrey D, Castot A, Pessayre D, Merigot P, Machayekhi JP, Feldmann G, Lenoir A, Rueff B, Benhamou JP (1986) Amodiaquine-induced hepatitis. A report of seven cases. Ann Intern Med 104: 801–803

    PubMed  CAS  Google Scholar 

  37. Larrey D, Erlinger S (1988) Drug-induced cholestasis. Bailliere’s Clinical Gastroenterol 12:423–452

    Article  Google Scholar 

  38. Larrey D, Freneaux E, Berson A, Babany G, Degott C, Valla D, Pessayre D, Benhamou JP (1988) Peliosis hepatis induced by 6-thioguanine administration. Gut 29: 1265–1269

    Article  PubMed  CAS  Google Scholar 

  39. Larrey D, Hadengue A, Pessayre D, Choudat L, Degott C, Benhamou JP (1987) Carbamazepine-induced acute cholangitis. Dig Dis Sci 32: 554–557

    Article  PubMed  CAS  Google Scholar 

  40. Larrey D, Michel H (1993) Pathologie biliaire dûe aux médicaments. Gastroenterol clin biol (in press)

    Google Scholar 

  41. Larrey D, Pessayre D (1988) Genetic factors in hepatotoxicity. In: Liver cells and drugs. Ed Guillouzo A, Libbey J, London 164: 143–152

    Google Scholar 

  42. Larrey D, Pessayre D, Duhamel G, Casier A, Degott C, Feldmann G, Erlinger S, Benhamou JP (1986) Prolonged cholestasis after ajmaline-induced acute hepatitis. J Hepatol 2: 81–87

    Article  PubMed  CAS  Google Scholar 

  43. Larrey D, Rueff B, Pessayre D, Danan G, Algard M, Geneve J, Benhamou JP (1986) Cross hepatotoxicity between tricyclic antidepressants. Gut 27: 726–727

    Article  PubMed  CAS  Google Scholar 

  44. Larrey D, Vial T, Micaleff A, Babany G, Morichau-Beauchant M, Michel H, Benhamou JP (1992) Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut 33: 368–371

    Article  PubMed  CAS  Google Scholar 

  45. Larrey D, Vial T, Pauwels A, Castot A, Biour M, David M, Michel H (1992) Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 117: 129–132

    PubMed  CAS  Google Scholar 

  46. Levy M, Goodman M, Van Dyne BJ, Hatton S (1981) Granulomatous hepatitis secondary to carbamazepine. Ann Intern Med 95: 64–65

    PubMed  CAS  Google Scholar 

  47. Lewis JH, Ranard RC, Caruso A, Jackson LK, Mullick F, Ishak KG, Seeff LB, Zimmermann HJ (1989) Amiodarone hepatotoxicity: prevalence and clinico-pathologic correlations among 104 patients. Hepatology 9: 679–685

    Article  PubMed  CAS  Google Scholar 

  48. Loeper J, Descatoire V, Amouyal G, Lettéron P, Larrey D, Pessayre D (1989) Presence of covalently bound metabolites on rat hepatocyte plasma membrane proteins after administration of isaxonine, a drug leading to immunoallergic hepatitis in man. Hepatology 9: 675–678

    Article  PubMed  CAS  Google Scholar 

  49. Loeper J, Descatoire V, Maurice M, Beaune P, Feldmann G, Larrey D, Pessayre D (1990) Presence of functional cytochrome P-450 on isolated rat hepatocyte plasma membrane. Hepatology 11: 850–858

    Article  PubMed  CAS  Google Scholar 

  50. Ludwig J, Kim CH, Wiesner RH, Krom RAF (1989) Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy? Hepatology 9: 215–218

    Article  PubMed  CAS  Google Scholar 

  51. Lüllmann H, Lüllmann-Rauch R, Wassermann O (1975) Drug-induced phospho-lipidoses. CRC Critical Rev Toxicol 4: 185–242

    Google Scholar 

  52. Makuuchi M, Sukigara M, Mori T, Kobayashi J, Yamazaki S, Hasegawa H (1985) Bile duct necrosis: compilation of transcatheter hepatic arterial embolization. Radiology 156: 331–334

    PubMed  CAS  Google Scholar 

  53. McKnight JA, McCance DR, Atkinson AB, Crothers JG (1989) Changes in glucose tolerance and development of gallstones during high dose treatment with octreotide for acromegaly. Br Med J 299: 1162–1163

    Article  Google Scholar 

  54. McMaster KR, Hennigar GG (1981) Drug-induced granulomatous hepatitis. Lab Invest 44: 61–73

    PubMed  Google Scholar 

  55. Meyer WJ, Wiener I, Emory LE, Cole CM, Isenberg N, Fagan CJ et al. (1992) Cholelithiasis associated with medroxyprogesterone acetate therapy in men. Res Comm Chem Pathol Pharmacol 75: 69–84

    Google Scholar 

  56. Miguet JP, Vuitton D, Allemand H et al. (1980) Une épidémie d’ictères dus à l’association troléandomycine-contraceptifs oraux. Gastroenterol Clin Biol 4: 420–424

    PubMed  CAS  Google Scholar 

  57. Moesch C, Gainant A, Sautereau D (1988) Lithiase biliaire de glafénine. Identification par spectrophotométrie infrarouge. Gastroenterol Clin Biol 12: 387–389

    PubMed  CAS  Google Scholar 

  58. Morgan MY, Reshef R, Shah RR, Oates NS, Smith RL, Sherlock S (1984) Impaired oxidation of debrisoquine in patients with perhexiline liver injury. Gut 1057–1064

    Google Scholar 

  59. Neiderhiser DH (1986) Acute acalculous cholecystitis induced by lysophosphati-dylcholine. Am J Pathol 124: 559–563

    PubMed  CAS  Google Scholar 

  60. Neuberger, J, Forman D, Doll R, Williams R (1986) Oral contraceptives and hepatocellular carcinoma. Br Med J 292: 1355–1357

    Article  CAS  Google Scholar 

  61. Pagliaro L, Campesi G, Aguglia F (1969) Barbiturate jaundice. Report of a case due to a barbital-containing drug, with positive rechallenge to phenobarbital. Gastroenterology 56: 938–943

    PubMed  CAS  Google Scholar 

  62. Paquette P, Campos LT, Flax I, McElmurry S, Dossey JE, Miro-Quesada M (1987) Prevention and treatment of sclerosing cholangitis related to chemotherapy delivered by infusaid pump. Proc Am Soc Clin Oncol 6: 89

    Google Scholar 

  63. Pariente A, Hamoud A, Goldfain et al. (1989) Hépatites à la clométacine (Dupé-ran). Etude rétrospective de 30 cas. Un modèle d’hépatite immunoallergique. Gastroenterol Clin Biol 13: 769–774

    PubMed  CAS  Google Scholar 

  64. Parry SW, Pelias ME, Browder W (1988) Acalculous hypersensitivity cholecystitis: hypothesis of a new clincopathologic entity. Surgery 104: 911–916

    PubMed  CAS  Google Scholar 

  65. Pessayre D, Bichara M, Feldmann G, Degott C, Potet F, Benhamou JP (1979) Perhexiline maleate-induced cirrhosis. Gastroenterology 76: 170–177

    PubMed  CAS  Google Scholar 

  66. Pessayre D, Larrey D (1988) Acute and chronic drug-induced hepatitis. Baillere’s Clin Gastroenterol 2: 385–422

    Article  CAS  Google Scholar 

  67. Pessayre D, Larrey D (1988) Mechanisms of drug-induced hepatitis. In: Liver Cells and Drugs. Ed. Guillouzo A, Libbey J London 164: 129–142

    Google Scholar 

  68. Pessayre D, Larrey D, Funck-Bretano D, Benhamou JP (1985) Drug interactions and hepatitis produced by some macrolide antibiotics. J Antimicrob Chemother 16 (suppl A): 181–194

    PubMed  CAS  Google Scholar 

  69. Pitre J, Houssin D, Louvel A, Vigouroux C, Gaudric M, Chapuis Y (1991) Cho-langite ectasiante et cirrhose biliaire secondaire après chimiothérapie intra-artérielle hépatique. Gastroenterol Clin Biol 15: 350–354

    PubMed  CAS  Google Scholar 

  70. Poucell S, Ireton J, Valencia-Mayoral P, Downar E, Larratt L, Patterson J, Blen-dis L, Phillips J (1984) Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies. Gastroenterology 86: 926–936

    PubMed  CAS  Google Scholar 

  71. Prescott LF (1983) Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs 25: 290–314

    Article  PubMed  CAS  Google Scholar 

  72. Prigrau C, Pahissa A, Gropper S, Sureda D, Martínez-Vásquez JM (1989) Ceftriaxone-associated biliary pseudolithiasis in adults. Lancet 1: 165

    Article  Google Scholar 

  73. Review by an International Group (1983) Histopathology of the intrahepatic biliary tract. Liver 3: 161–175

    Google Scholar 

  74. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW (1979) The cooperative liver tumor study group — epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242: 645–648

    Article  Google Scholar 

  75. Rougier P (1986) Chimiothérapie intra-artérielle hépatique des métastases isolées des adénocarcinomes colo-rectaux. Gastroenterol Clin Biol 10: 122–130

    PubMed  CAS  Google Scholar 

  76. Schaad UB, Wedgwood-Krucko J, Tschaeppeler H (1988) Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet 2: 1411–1413

    Article  PubMed  CAS  Google Scholar 

  77. Seeff LB, Cuccherini BA, Zimmerman HJ, Adler EA, Benjamin SB (1986) Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. Ann Intern Med 104: 399–404

    PubMed  CAS  Google Scholar 

  78. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W (1986) Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 105: 179–183

    PubMed  CAS  Google Scholar 

  79. Simon JB, Manley PN, Brien JF, Armstrong PW (1984) Amiodarone hepatotoxi-city simulating alcoholic liver disease. N Engl J Med 311: 167–172

    Article  PubMed  CAS  Google Scholar 

  80. Spes CH, Angermann CE, Beyer RW, Schreiner J, Lehnert P (1990) Increased incidence of cholelithiasis in heart transplant recipients receiving cyclosporin therapy. Transplantation 9: 404–407

    CAS  Google Scholar 

  81. Spielberg SP, Gordon GB, Blake DA, Goldstein DA, Herlong HF (1981) Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med 305: 722–727

    Article  PubMed  CAS  Google Scholar 

  82. Steiner A, Weisser B, Vetter WA (1991) A comparative review of the adverse effects of treatments for hyperlipidaemia. Drug Saftety 6: 118–130

    Article  CAS  Google Scholar 

  83. Stolzer B, Miller G, White WA, Zuckerbrod M (1950) Postarsenical obstructive jaundice complicated by xanthomatosis and diabetes mellitus. Am J Med 9: 124–132

    Article  PubMed  CAS  Google Scholar 

  84. Stricker BHCH, Block R, Claas FHJ, Parys GEV, Desmet VJ (1988) Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology 8: 599–606

    Article  PubMed  CAS  Google Scholar 

  85. Stricker BHCH, Spoelstra P (1985) Drug-induced hepatic injury. A comprehensive survey of the literature on adverse drug reactions up to January 1985 ; Elsevier, Amsterdam 1985

    Google Scholar 

  86. Valla D, Benhamou JP (1988) Liver diseases related to oral contraceptives. Dig Dis 6: 76–86

    Article  PubMed  CAS  Google Scholar 

  87. Valla D, Benhamou JP (1988) Drug-induced vascular and sinusoidal lesions of the liver. Baillere’s Clin Gastroenterol 2: 481–500

    Article  CAS  Google Scholar 

  88. Yeung E, Jackson J, Finn JP, Thomas MG, Benjamin IS, Adam A (1990) Acal-culous cholecystis complicating hepatic intraarterial Lipiodol: case report. Cardi-ovasc Intervent Radiol 12: 80–82

    Article  Google Scholar 

  89. Zafrani ES, Pinaudeau Y, Dhumeaux D (1983) Drug-induced vascular lesions of the liver. Arch Intern Med 143: 495–802

    Article  PubMed  CAS  Google Scholar 

  90. Zimmerman HJ (1978) Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver. Appleton-Century-Crofts, New York 1978

    Google Scholar 

  91. Zimmerman HJ, Lewis JH (1987) Drug-induced cholestasis. Med Toxicol 2: 112–160

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’Hépato-gastroentérologie, Hôpital Saint-Eloi, Montpellier, France

    D. Larrey

Authors
  1. D. Larrey
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Larrey, D. (1993). Drug-Induced Injuries of the Liver and Biliary Tract. In: Drug-Induced Injury to the Digestive System. Springer, Milano. https://doi.org/10.1007/978-88-470-2220-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2220-1_10

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2222-5

  • Online ISBN: 978-88-470-2220-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation